Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Horst Homann"'
Autor:
Martine Marigliano, Dominique Roecklin, Valérie Calenda, Yves Poitevin, Stéphane Paul, Gilles Cauet, Etienne Régulier, Jacqueline Kintz, Catherine Ledoux, Horst Homann
Publikováno v:
Cancer Gene Therapy. 8:45-54
Based on the observation that the growth of solid tumors is dependent on the formation of new blood vessels, therapeutic strategies aimed at inhibiting angiogenesis have been proposed. A number of proteins with angiostatic activity have been describe
Autor:
Serge Braun, Andrea Pavirani, Frédéric Perraud, Christine Thioudellet, Reiner Bischoff, Horst Homann, Majid Mehtali, Marie-Christine Claudepierre, Monika Lusky, Catherine Escriou
Publikováno v:
Cytotechnology. 30:181-189
We have developed and characterized cultures of healthy and dystrophic canine myoblasts for the evaluation of various gene transfer protocols. The number of desmin-positive myoblasts was elevated (>>80%) in cultures of myoblasts obtained from differe
Autor:
Etienne Régulier, Ronald Rooke, R Bruce Acres, Fabienne Stoeckel, Dominique Villeval, Stéphane Paul, Marie-Paule Kieny, Horst Homann, Michel Geist, Jean-Marc Balloul, Yves Poitevin
Publikováno v:
Cancer gene therapy. 9(5)
Immune responses to tumor-associated antigens are often dampened by a tumor-induced state of immune anergy. Previous work has attempted to overcome tumor-induced T-cell anergy by the direct injection of vectors carrying the genes encoding one of a va
Publikováno v:
Gene therapy. 9(5)
Some of the therapeutic genes to be delivered by means of recombinant adenoviruses code for toxic compounds. Expression of these sequences can be deleterious to the complementation cells used for vector production, making it often difficult to genera
Autor:
Xuetao Cao, Zhihai Qin, Etienne Régulier, B Wang, M Zhang, Y Yu, J Guo, Horst Homann, T Chen, Dianwen Ju
Publikováno v:
Gene therapy. 9(12)
Chemokine gene transfer represents a promising approach in the treatment of malignancies. Macrophage-derived chemokine (MDC) (CCL22) belongs to the CC chemokine family and is a strong chemoattractant for dendritic cells (DC), NK cells and T cells. Us
Autor:
Horst Homann
Publikováno v:
Biofutur. 1998:88-89
Des cellules de singe genetiquement modifiees et productrices d'interleukine 2 sont testees chez l'homme pour traiter les cancers.